You are here

blood cancer

GSK to pull blood cancer drug from US market after study failure

BioPharma Dive

Tue, 11/22/22 - 11:08 am

clinical trials

Multiple Myeloma

Merck & Co. inks $1.4B blood cancer biotech buyout to muscle in on Bristol Myers, Novartis

Fierce Biotech

Mon, 11/21/22 - 10:34 am

Imago BioSciences

After chat with FDA, ImmunoGen delays pivotal top-line data on blood cancer ADC to 2024

Fierce Biotech

Wed, 08/31/22 - 10:31 am

antibody drug conjugate

pivekimab sunirine

Novartis suspends platform trial, advancement shot of four blood cancer assets drop

Clinical Trials Arena

Wed, 07/13/22 - 10:07 am

clinical trials

uterine leiomyoma

AACR: AbbVie's navitoclax goes after tough blood cancer, not yet reaching overall survival benchmark

Fierce Biotech

Tue, 04/12/22 - 08:31 pm

ASH: Roche uncorks eyepopping responses in bispecific test, hoping to add a jewel to its future portfolio

Endpoints

Sun, 12/12/21 - 11:31 pm

bispecific antibodies

Mei, with Bayer and Gilead in its sights, posts pivotal data on blood cancer prospect

Fierce Biotech

Tue, 11/30/21 - 10:41 am

follicular lymphoma

Gilead Sciences

Amid Amgen's similar struggles, AstraZeneca slams the brakes on MCL-1 blood cancer drug

Fierce Biotech

Wed, 10/20/21 - 10:20 am

clinical trials

FDA hits pause on Protagonist's blood cancer med after mouse study turns up skin tumors

Fierce Biotech

Sat, 09/18/21 - 08:21 pm

Protagonist Therapeutics

clinical trials

FDA approves BeiGene's Brukinsa in rare blood cancer amid company's US expansion plans

Endpoints

Thu, 09/2/21 - 10:29 am

Not waving but drowning: Takeda's blood cancer drug flunks phase 3, dealing further blow to hopes of approval flurry

Fierce Biotech

Thu, 09/2/21 - 09:38 am

clinical trials

Allogene sets out to prove that their off-the-shelf approach to CAR-T can beat the personalized approach

Endpoints

Wed, 05/19/21 - 11:11 pm

Oxford BioTherapeutics to research cell therapies for Gilead’s Kite

Pharmaforum

Thu, 01/7/21 - 11:28 am

Gilead Sciences

Oxford BioTherapeutics

Armed with FDA nod, Otsuka unit Astex preps to launch oral chemotherapy Inqovi

Fierce Pharma

Mon, 08/3/20 - 10:24 am

Novartis-backed Gamida hits goal in phase 3 cancer trial

Fierce Biotech

Tue, 05/12/20 - 12:04 pm

clinical trials

AbbVie, Roche's Venclexta endangers AML approval with flopped confirmatory trial

Fierce Pharma

Mon, 03/2/20 - 11:07 pm

Celgene taps Bristol-Myers salesforce to bolster key blood cancer launches

Fierce Pharma

Wed, 01/15/20 - 11:13 pm

Bristol-Myers Squibb

How Viagra could boost a widely used blood cancer treatment

Fierce Biotech

Thu, 10/10/19 - 12:59 pm

Led by BioNTech, six biotechs line up for October IPOs

Endpoints

Sat, 09/28/19 - 04:38 pm

ADC Therapeutics

Frequency Therapeutics

Aprea Therapeutics

Monopar Therapeutics

Deepening US footprint, AstraZeneca-partnered French biotech Innate shoots for $100M IPO

Endpoints

Mon, 09/23/19 - 10:49 am

Pages